Selected article for: "ARDS respiratory distress syndrome and global public health emergency"
Author: Mannino, Federica; Bitto, Alessandra; Irrera, Natasha
Title: Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
  • Cord-id: redcb4xd
  • Document date: 2020_11_26
    • ID: redcb4xd
    Snippet: The new coronavirus outbreak was first identified in Wuhan, China, in December 2019, and has turned out to be a global health emergency, affecting millions of people worldwide. Coronavirus disease 19 (COVID-19), caused by the SARS-CoV-2 virus, can manifest with flu-like symptoms and can be complicated by severe pneumonia with acute respiratory distress syndrome (ARDS); however a large percentage of infected individuals do not have symptoms but contribute to the spread of the disease. Severe acut
    Document: The new coronavirus outbreak was first identified in Wuhan, China, in December 2019, and has turned out to be a global health emergency, affecting millions of people worldwide. Coronavirus disease 19 (COVID-19), caused by the SARS-CoV-2 virus, can manifest with flu-like symptoms and can be complicated by severe pneumonia with acute respiratory distress syndrome (ARDS); however a large percentage of infected individuals do not have symptoms but contribute to the spread of the disease. Severe acute respiratory syndrome coronavirus-2 infection has become a global public health emergency since no available treatment seems effective and it is hard to manage the several complications caused by an intense release of cytokines. This paper reviews the current options on drugs used to reduce the deadly effects of the cytokine storm.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and acute phase: 1, 2, 3, 4
    • action mechanism and acute phase protein: 1, 2
    • action mechanism and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • action mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • action mechanism and additional study: 1
    • action mechanism and adenosine analog: 1, 2
    • activate leukocyte and adaptive immunity: 1
    • activate pathway and acute lung injury: 1, 2, 3
    • activate pathway and acute respiratory distress syndrome: 1, 2
    • activate pathway and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • activate pathway and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • activate pathway and adaptive immunity: 1
    • activate pathway induce and acute respiratory syndrome: 1
    • acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
    • acute lung injury and additional study: 1
    • acute phase and additional study: 1, 2
    • acute phase and adenosine analog: 1